+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Specialty Generics Market: Global Industry Analysis, Trends, Market Size, and Forecasts up to 2030

  • Report

  • 255 Pages
  • December 2023
  • Region: Global
  • Infinium Global Research
  • ID: 5542995
Description Jump to:
The report on the global specialty generics market provides qualitative and quantitative analysis for the period from 2021-2030. The global specialty generics market was valued at USD 69.69 billion in 2022 and is expected to reach USD 143.69 billion in 2030, with a CAGR of a 9.60% during the forecast period 2023-2030. The study on specialty generics market covers the analysis of the leading geographies such as North America, Europe, Asia Pacific, and RoW for the period of 2021-2030.

The report on specialty generics market is a comprehensive study and presentation of drivers, restraints, opportunities, demand factors, market size, forecasts, and trends in the global specialty generics market over the period of 2021-2030. Moreover, the report is a collective presentation of primary and secondary research findings.

Porter's five forces model in the report provides insights into the competitive rivalry, supplier and buyer positions in the market and opportunities for the new entrants in the global specialty generics market over the period of 2021-2030. Further, Growth Matrix gave in the report brings an insight into the investment areas that existing or new market players can consider.

Report Findings

1) Drivers

  • The rise in the incidences of chronic diseases is majorly propelling the market specialty generics market growth.
  • The rising frequency of patent expirations fuels the specialty generics market.

2) Restraints

  • Complexity, workforce, and raw material sourcing pose significant challenges for the pharmaceutical industry, potentially hindering specialty generics market growth.

3) Opportunities

  • Enhanced pharmaceutical infrastructure in developing regions can attract investment in the specialty generic market, creating growth opportunities for industry players.

Research Methodology

A) Primary Research

The primary research involves extensive interviews and analysis of the opinions provided by the primary respondents. The primary research starts with identifying and approaching the primary respondents, the primary respondents are approached include
1. Key Opinion Leaders associated
2. Internal and External subject matter experts
3. Professionals and participants from the industry

The primary research respondents typically include

1. Executives working with leading companies in the market under review
2. Product/brand/marketing managers
3. CXO level executives
4. Regional/zonal/ country managers
5. Vice President level executives.

B) Secondary Research

Secondary research involves extensive exploring through the secondary sources of information available in both the public domain and paid sources. Each research study is based on over 500 hours of secondary research accompanied by primary research. The information obtained through the secondary sources is validated through the crosscheck on various data sources.

The secondary sources of the data typically include

1. Company reports and publications
2. Government/institutional publications
3. Trade and associations journals
4. Databases such as WTO, OECD, World Bank, and among others.
5. Websites and publications by research agencies

Segment Covered

The global specialty generics market is segmented on the basis of type, application, and distribution channel.

The Global Specialty Generics Market by Type

  • Injectables
  • Oral
  • Others

The Global Specialty Generics Market by Application

  • Oncology
  • Infectious Diseases
  • Autoimmune Diseases
  • Others

The Global Specialty Generics Market by Distribution Channel

  • Specialty Pharmacies
  • Retail Pharmacies
  • Hospital Pharmacies

Company Profiles

The companies covered in the report include
  • Teva Pharmaceutical Industries Ltd.
  • Bausch Health Companies Inc.
  • Novartis AG
  • Hikma Pharmaceuticals PLC
  • Mallinckrodt Pharmaceuticals
  • Dr. Reddy’s Laboratories Ltd.
  • Endo International plc
  • Apotex Inc.
  • Sun Pharmaceutical Industries Ltd.
  • STADA Arzneimittel AG

What does this Report Deliver?

1. Comprehensive analysis of the global as well as regional markets of the specialty generics market.
2. Complete coverage of all the segments in the specialty generics market to analyze the trends, developments in the global market and forecast of market size up to 2030.
3. Comprehensive analysis of the companies operating in the global specialty generics market. The company profile includes analysis of product portfolio, revenue, SWOT analysis and latest developments of the company.
4. Growth Matrix presents an analysis of the product segments and geographies that market players should focus to invest, consolidate, expand and/or diversify.

This product will be delivered within 1-3 business days.

Table of Contents

Chapter 1. Preface
1.1. Report Description
1.2. Research Methods
1.3. Research Approaches
Chapter 2. Executive Summary
2.1. Specialty Generics Market Highlights
2.2. Specialty Generics Market Projection
2.3. Specialty Generics Market Regional Highlights
Chapter 3. Global Specialty Generics Market Overview
3.1. Introduction
3.2. Market Dynamics
3.2.1. Drivers
3.2.2. Restraints
3.2.3. Opportunities
3.3. Porter's Five Forces Analysis
3.4. Growth Matrix Analysis
3.4.1. Growth Matrix Analysis by Type
3.4.2. Growth Matrix Analysis by Application
3.4.3. Growth Matrix Analysis by Distribution Channel
3.4.4. Growth Matrix Analysis by Region
3.5. Value Chain Analysis of Specialty Generics Market
Chapter 4. Specialty Generics Market Macro Indicator Analysis
Chapter 5. Company Profiles and Competitive Landscape
5.1. Competitive Landscape in the Global Specialty Generics Market
5.2. Companies Profiles
5.2.1. Teva Pharmaceutical Industries Ltd.
5.2.2. Bausch Health Companies Inc.
5.2.3. Novartis AG
5.2.4. Hikma Pharmaceuticals PLC
5.2.5. Mallinckrodt Pharmaceuticals
5.2.6. Dr. Reddy’s Laboratories Ltd.
5.2.7. Endo International plc
5.2.8. Apotex Inc.
5.2.9. Sun Pharmaceutical Industries Ltd.
5.2.10. STADA Arzneimittel AG
Chapter 6. Global Specialty Generics Market by Type
6.1. Injectables
6.2. Oral
6.3. Others
Chapter 7. Global Specialty Generics Market by Application
7.1. Oncology
7.2. Infectious Diseases
7.3. Autoimmune Diseases
7.4. Others
Chapter 8. Global Specialty Generics Market by Distribution Channel
8.1. Specialty Pharmacies
8.2. Retail Pharmacies
8.3. Hospital Pharmacies
Chapter 9. Global Specialty Generics Market by Region 2023-2030
9.1. North America
9.1.1. North America Specialty Generics Market by Type
9.1.2. North America Specialty Generics Market by Application
9.1.3. North America Specialty Generics Market by Distribution Channel
9.1.4. North America Specialty Generics Market by Country
9.1.4.1. The U.S. Specialty Generics Market
9.1.4.1.1. The U.S. Specialty Generics Market by Type
9.1.4.1.2. The U.S. Specialty Generics Market by Application
9.1.4.1.3. The U.S. Specialty Generics Market by Distribution Channel
9.1.4.2. Canada Specialty Generics Market
9.1.4.2.1. Canada Specialty Generics Market by Type
9.1.4.2.2. Canada Specialty Generics Market by Application
9.1.4.2.3. Canada Specialty Generics Market by Distribution Channel
9.1.4.3. Mexico Specialty Generics Market
9.1.4.3.1. Mexico Specialty Generics Market by Type
9.1.4.3.2. Mexico Specialty Generics Market by Application
9.1.4.3.3. Mexico Specialty Generics Market by Distribution Channel
9.2. Europe
9.2.1. Europe Specialty Generics Market by Type
9.2.2. Europe Specialty Generics Market by Application
9.2.3. Europe Specialty Generics Market by Distribution Channel
9.2.4. Europe Specialty Generics Market by Country
9.2.4.1. Germany Specialty Generics Market
9.2.4.1.1. Germany Specialty Generics Market by Type
9.2.4.1.2. Germany Specialty Generics Market by Application
9.2.4.1.3. Germany Specialty Generics Market by Distribution Channel
9.2.4.2. United Kingdom Specialty Generics Market
9.2.4.2.1. United Kingdom Specialty Generics Market by Type
9.2.4.2.2. United Kingdom Specialty Generics Market by Application
9.2.4.2.3. United Kingdom Specialty Generics Market by Distribution Channel
9.2.4.3. France Specialty Generics Market
9.2.4.3.1. France Specialty Generics Market by Type
9.2.4.3.2. France Specialty Generics Market by Application
9.2.4.3.3. France Specialty Generics Market by Distribution Channel
9.2.4.4. Italy Specialty Generics Market
9.2.4.4.1. Italy Specialty Generics Market by Type
9.2.4.4.2. Italy Specialty Generics Market by Application
9.2.4.4.3. Italy Specialty Generics Market by Distribution Channel
9.2.4.5. Rest of Europe Specialty Generics Market
9.2.4.5.1. Rest of Europe Specialty Generics Market by Type
9.2.4.5.2. Rest of Europe Specialty Generics Market by Application
9.2.4.5.3. Rest of Europe Specialty Generics Market by Distribution Channel
9.3. Asia Pacific
9.3.1. Asia Pacific Specialty Generics Market by Type
9.3.2. Asia Pacific Specialty Generics Market by Application
9.3.3. Asia Pacific Specialty Generics Market by Distribution Channel
9.3.4. Asia Pacific Specialty Generics Market by Country
9.3.4.1. China Specialty Generics Market
9.3.4.1.1. China Specialty Generics Market by Type
9.3.4.1.2. China Specialty Generics Market by Application
9.3.4.1.3. China Specialty Generics Market by Distribution Channel
9.3.4.2. Japan Specialty Generics Market
9.3.4.2.1. Japan Specialty Generics Market by Type
9.3.4.2.2. Japan Specialty Generics Market by Application
9.3.4.2.3. Japan Specialty Generics Market by Distribution Channel
9.3.4.3. India Specialty Generics Market
9.3.4.3.1. India Specialty Generics Market by Type
9.3.4.3.2. India Specialty Generics Market by Application
9.3.4.3.3. India Specialty Generics Market by Distribution Channel
9.3.4.4. South Korea Specialty Generics Market
9.3.4.4.1. South Korea Specialty Generics Market by Type
9.3.4.4.2. South Korea Specialty Generics Market by Application
9.3.4.4.3. South Korea Specialty Generics Market by Distribution Channel
9.3.4.5. Australia Specialty Generics Market
9.3.4.5.1. Australia Specialty Generics Market by Type
9.3.4.5.2. Australia Specialty Generics Market by Application
9.3.4.5.3. Australia Specialty Generics Market by Distribution Channel
9.3.4.6. Rest of Asia-Pacific Specialty Generics Market
9.3.4.6.1. Rest of Asia-Pacific Specialty Generics Market by Type
9.3.4.6.2. Rest of Asia-Pacific Specialty Generics Market by Application
9.3.4.6.3. Rest of Asia-Pacific Specialty Generics Market by Distribution Channel
9.4. RoW
9.4.1. RoW Specialty Generics Market by Type
9.4.2. RoW Specialty Generics Market by Application
9.4.3. RoW Specialty Generics Market by Distribution Channel
9.4.4. RoW Specialty Generics Market by Sub-region
9.4.4.1. Latin America Specialty Generics Market
9.4.4.1.1. Latin America Specialty Generics Market by Type
9.4.4.1.2. Latin America Specialty Generics Market by Application
9.4.4.1.3. Latin America Specialty Generics Market by Distribution Channel
9.4.4.2. Middle East Specialty Generics Market
9.4.4.2.1. Middle East Specialty Generics Market by Type
9.4.4.2.2. Middle East Specialty Generics Market by Application
9.4.4.2.3. Middle East Specialty Generics Market by Distribution Channel
9.4.4.3. Africa Specialty Generics Market
9.4.4.3.1. Africa Specialty Generics Market by Type
9.4.4.3.2. Africa Specialty Generics Market by Application
9.4.4.3.3. Africa Specialty Generics Market by Distribution Channel

Companies Mentioned

  • Teva Pharmaceutical Industries Ltd.
  • Bausch Health Companies Inc.
  • Novartis AG
  • Hikma Pharmaceuticals PLC
  • Mallinckrodt Pharmaceuticals
  • Dr. Reddy’s Laboratories Ltd.
  • Endo International plc
  • Apotex Inc.
  • Sun Pharmaceutical Industries Ltd.
  • STADA Arzneimittel AG

Table Information

Report AttributeDetails
No. of Pages255
PublishedDecember 2023
Forecast Period2022 - 2030
Estimated Market Value ( USD ) in 2022 $ 69.69 Billion
Forecasted Market Value ( USD ) by 2030 $ 143.69 Billion
Compound Annual Growth Rate9.6%
Regions CoveredGlobal
No. of Companies Mentioned10

Related Topics

Related Reports

Specialty Generics Global Market Report 2024 - Product Image

Specialty Generics Global Market Report 2024

  • Report
  • 200 Pages
  • Global
From
Global Specialty Generics Market by Type (Injectables, Oral Drugs), Application (Hepatitis C, Inflammatory Conditions, Multiple Sclerosis), End-Use - Forecast 2024-2030 - Product Image

Global Specialty Generics Market by Type (Injectables, Oral Drugs), Application (Hepatitis C, Inflammatory Conditions, Multiple Sclerosis), End-Use - Forecast 2024-2030

  • Report
  • 195 Pages
  • Global
From
Specialty Generics Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028 - Product Image

Specialty Generics Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028

  • Report
  • 182 Pages
  • Global
From
Global Specialty Generics Market Size, Share & Industry Trends Analysis Report By Type (Injectables, Oral Drugs, and Others), By Application, By End Use (Specialty Pharmacy, Retail Pharmacy, and Hospital Pharmacy), By Regional Outlook and Forecast, 2023 - 2030 - Product Image

Global Specialty Generics Market Size, Share & Industry Trends Analysis Report By Type (Injectables, Oral Drugs, and Others), By Application, By End Use (Specialty Pharmacy, Retail Pharmacy, and Hospital Pharmacy), By Regional Outlook and Forecast, 2023 - 2030

  • Report
  • 233 Pages
  • Global
From
Global Specialty Generics Market Report by Route of Administration, Indication, Distribution channel, and Region 2024-2032 - Product Image

Global Specialty Generics Market Report by Route of Administration, Indication, Distribution channel, and Region 2024-2032

  • Report
  • 134 Pages
  • Global
From
Copyright © 2002-2024 Research and Markets. All Rights Reserved.